SANTA MONICA, Calif., June 24, 2021 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI) ("BioVie" or "Company"), a clinical-stage company developing innovative drug therapies for the treatment of liver ...

Early initiation of diuretic therapy in patients with new onset cirrhotic ascites lowers 90-day mortality rate, according to a study in the American Journal of Gastroenterology. Researchers examined ...

Gender-specific trends in incidence and prevalence of pancreatic cancer: A Global Burden of Disease analysis in adults aged 70 and older (1990–2021). This is an ASCO Meeting Abstract from the 2025 ...

A multicenter study in Spain developed a new predictive model for surgical risk in patients with cirrhosis that may improve the prediction of postoperative mortality. The surgical risk prediction ...

Learn how beta-blockers, including carvedilol, can be used in advanced liver disease to manage portal hypertension and reduce first decompensation risk.

AKI — Increase in serum creatinine ≥0.3 mg/dl within 48 hr or increase ≥1.5 times baseline level Increase in serum creatinine ≥0.3 mg/dl within 48 hr or increase ≥1.5 times baseline level, which is ...

The role of NKTR-102 in women with platinum resistant/refractory ovarian cancer and failure on pegylated liposomal doxorubicin (PLD). Fibroblast growth factor receptor 4 (FGFR4) expression as a ...

Static ultrasound guidance is used to select and mark the site of needle insertion immediately before the procedure takes place. Dynamic ultrasound guidance, in contrast, is used to directly visualize ...

Sequana Medical NV received premarket approval from the U.S. FDA for its Alfapump system to treat recurrent or refractory ascites due to liver cirrhosis. Data from the Poseidon pivotal study showed ...

Research, headed by teams at Trinity College Dublin and University College Dublin, has uncovered how lipid-rich fluid in the abdomen, known as ascites, plays a central role in weakening the body’s ...